A Technique for More Precise Distinction Between Catagen and Telogen Human Hair Follicles Ex Vivo

    February 2018 in “ Journal of The American Academy of Dermatology ”
    Irene Hernández, Majid Alam, Christopher I. Platt, Jonathan A. Hardman, Eleanor Smart, Enrique Poblet, Marta Bertolini, Ralf Paus, Francisco Jiménez
    Image of study
    TLDR Researchers developed a new method using methylene blue staining to more accurately identify the growth stage of human hair follicles.
    In the study, researchers developed a technique using methylene blue (MB) staining to distinguish between late catagen and telogen human hair follicles (HFs) ex vivo, which is typically challenging with stereomicroscopic analysis alone. The study involved 800 follicular units (FUs) from 8 Caucasian male patients undergoing hair transplantation, with each patient contributing 100 FUs. The FUs containing catagen and/or telogen HFs were microdissected, stained with MB, and then evaluated. The MB staining improved the visualization of HF structures and allowed for correct hair cycle stage classification in 95.63% of cases, compared to 72.02% accuracy without MB staining. This method facilitates research on human catagen and telogen HFs without resorting to histology. The study also found a higher percentage of catagen HFs (6.7%) compared to telogen HFs (3.6%) in the patients, suggesting that the percentage of scalp telogen HFs may have been previously overestimated in the literature. The authors propose that the distribution of hair stages in healthy human scalp requires systematic re-evaluation.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 32 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 2 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

      community Sandalore: a scientific homemade approch

       20 upvotes 6 years ago
      The post discusses using Sandalore as a potential hair loss treatment, emphasizing precise measurements and safe handling. The user compares Sandalore's effects to Minoxidil and mentions preparing a solution with ethanol and DMSO.

      community Losing gains from 7 months of oral min, fin, dut.

      in Update  66 upvotes 11 months ago
      A user reported losing hair after 7 months of using oral minoxidil, finasteride, and dutasteride, but others reassured that this is likely just a shedding phase where old hairs fall out to make way for new growth. Some users experience sheds every 7-8 months and suggest staying consistent with treatment.

    Related Research

    5 / 5 results